-
The fda has approved the first naloxone hand-held auto-injector. It is intended for family members or caregivers to treat suspected opioid overdose. The auto-injector can be carried in a pocket or stored in a medicine cabinet. The product was reviewed under the agencys priority review program. It is marketed by Kaleo, Inc. as Evzio.
-
Bendopnea, which is defined as shortness of breath when bending over, has been found to be a dominant symptom in patients with heart failure. It appears to be caused by a further increase in filling pressures when bending over in patients with heart failure, especially when filling pressures are already high and the cardiac index is reduced.
-
In a study of veterans with no recent history of depression or opioid use, the risk of developing depression increased as the duration of opioid analgesic exposure increased.
-
The authors concluded that vitamin D supplementation in patients with fibromyalgia syndrome (FMS) and low levels of vitamin D might be an economical, safe, and effective therapy for patients with FMS.
-
-
-
-
-
Balk J. Resveratrol and cancer s of the prostate and breast. Altern Med Alert 2002;5(11):129-132.
-
Ramalanjaona G. Flower remedies for stress relief. Altern Med Alert 2002;5(11):132-134.
